BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25526010)

  • 1. Cetuximab-induced crusted pustular eruption with patchy alopecia.
    Fischer R; Blackmon J; Rajpara A
    Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.
    Bragg J; Pomeranz MK
    Dermatol Online J; 2007 Jan; 13(1):1. PubMed ID: 17511934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acneiform skin eruption in patients with metastatic colorectal carcinoma].
    Gethöffer K; Schneider LA; Peters T; Weber L; Scharffetter-Kochanek K
    Hautarzt; 2006 Jul; 57(7):628-31. PubMed ID: 16034631
    [No Abstract]   [Full Text] [Related]  

  • 4. Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose?
    Oskan F; Belka C; Manapov F
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):462-3. PubMed ID: 24074919
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
    Gencoglan G; Ceylan C
    Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Images in clinical medicine. Cetuximab-associated acneiform eruption.
    Moss JE; Burtness B
    N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
    [No Abstract]   [Full Text] [Related]  

  • 7. Unique presentations of epidermal growth factor receptor inhibitor-induced papulopustular eruption related to bacterial superinfection.
    Wiznia LE; Choi JN
    Dermatol Online J; 2013 Mar; 19(3):8. PubMed ID: 23552005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paronychia induced by the epidermal growth factor receptor inhibitor cetuximab.
    Lee SL; Tan BS; Chan LC
    J Oncol Pharm Pract; 2013 Sep; 19(3):273-8. PubMed ID: 23161875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecthymatous skin eruption during therapy with cetuximab.
    Navarini AA; Kamacharova I; Kerl K; Donghi D; Cozzio A
    Eur J Dermatol; 2011; 21(2):282-3. PubMed ID: 21489913
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosaceiform eruption induced by cetuximab.
    Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
    Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
    [No Abstract]   [Full Text] [Related]  

  • 11. Cetuximab-induced acneiform eruption and the response to isotretinoin.
    Vezzoli P; Marzano AV; Onida F; Alessi E; Galassi B; Tomirotti M; Berti E
    Acta Derm Venereol; 2008; 88(1):84-6. PubMed ID: 18176767
    [No Abstract]   [Full Text] [Related]  

  • 12. Malassezia folliculitis presented as acneiform eruption after cetuximab administration.
    Cholongitas E; Pipili C; Ioannidou D
    J Drugs Dermatol; 2009 Mar; 8(3):274-5. PubMed ID: 19271376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors.
    Kimyai-Asadi A; Jih MH
    Arch Dermatol; 2002 Jan; 138(1):129-31. PubMed ID: 11790188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acneiform eruption secondary to cetuximab].
    Herrera-Acosta E; Martín-Ezquerra G; Iglesias M; Umbert P
    Actas Dermosifiliogr; 2005 May; 96(4):252-4. PubMed ID: 16476378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant alopecia areata and hypertrichosis after infliximab therapy: rara avis.
    Akarsu S; Tok F; Tekin L
    Acta Reumatol Port; 2013; 38(1):49-50. PubMed ID: 24131912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nursing management of epidermal growth factor receptor inhibitor-induced toxicities.
    Dunsford J
    Clin J Oncol Nurs; 2008 Jun; 12(3):405-7. PubMed ID: 18515238
    [No Abstract]   [Full Text] [Related]  

  • 17. Perifollicular xanthomas associated with epidermal growth factor receptor inhibitor therapy.
    Eames T; Kroth J; Flaig MJ; Ruzicka T; Wollenberg A
    Acta Derm Venereol; 2010 Mar; 90(2):202-3. PubMed ID: 20169314
    [No Abstract]   [Full Text] [Related]  

  • 18. Sebaceous glands as the primary target of EGFR-inhibitors in the development of papulopustular eruption.
    Takata T; Tarutani M; Zouboulis CC; Sano S
    J Dermatol Sci; 2012 May; 66(2):165-8. PubMed ID: 22440861
    [No Abstract]   [Full Text] [Related]  

  • 19. Papulo-pustular eruption during cetuximab treatment.
    Satta R; Cuccuru MA; Pirodda C; Cottoni F
    G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment with adapalene of cetuximab-induced acneiform eruptions.
    Taguchi K; Fukunaga A; Okuno T; Nishigori C
    J Dermatol; 2012 Sep; 39(9):792-4. PubMed ID: 22168666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.